IRIS
SILVESTRIS, Nicola
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.183
EU - Europa 4.705
AS - Asia 3.418
SA - Sud America 1.227
Continente sconosciuto - Info sul continente non disponibili 179
AF - Africa 148
OC - Oceania 4
Totale 14.864
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.914
RU - Federazione Russa 2.468
SG - Singapore 1.358
BR - Brasile 991
CN - Cina 670
IE - Irlanda 616
IT - Italia 597
HK - Hong Kong 532
SE - Svezia 363
VN - Vietnam 253
DE - Germania 151
BD - Bangladesh 120
FR - Francia 109
IN - India 104
CA - Canada 99
GB - Regno Unito 95
AR - Argentina 90
MX - Messico 78
ID - Indonesia 69
FI - Finlandia 68
AT - Austria 64
IQ - Iraq 53
NL - Olanda 44
EC - Ecuador 43
ZA - Sudafrica 32
TR - Turchia 30
MA - Marocco 29
UZ - Uzbekistan 26
CO - Colombia 24
JP - Giappone 24
PK - Pakistan 24
JM - Giamaica 22
PL - Polonia 22
MY - Malesia 21
VE - Venezuela 20
ES - Italia 18
SA - Arabia Saudita 16
UA - Ucraina 16
CR - Costa Rica 15
TN - Tunisia 15
EG - Egitto 14
NP - Nepal 14
PY - Paraguay 14
CL - Cile 13
DZ - Algeria 13
PH - Filippine 13
KE - Kenya 12
PE - Perù 12
UY - Uruguay 12
AE - Emirati Arabi Uniti 11
CZ - Repubblica Ceca 11
EE - Estonia 11
TH - Thailandia 10
GT - Guatemala 9
HN - Honduras 9
BO - Bolivia 8
IL - Israele 8
SC - Seychelles 7
ET - Etiopia 6
JO - Giordania 6
PS - Palestinian Territory 6
SN - Senegal 6
AL - Albania 5
AZ - Azerbaigian 5
CI - Costa d'Avorio 5
LT - Lituania 5
PA - Panama 5
TT - Trinidad e Tobago 5
AO - Angola 4
BE - Belgio 4
BS - Bahamas 4
DO - Repubblica Dominicana 4
IR - Iran 4
KG - Kirghizistan 4
LB - Libano 4
LK - Sri Lanka 4
NO - Norvegia 4
OM - Oman 4
SY - Repubblica araba siriana 4
AU - Australia 3
BA - Bosnia-Erzegovina 3
BG - Bulgaria 3
BY - Bielorussia 3
BZ - Belize 3
GR - Grecia 3
LV - Lettonia 3
MK - Macedonia 3
PR - Porto Rico 3
PT - Portogallo 3
RO - Romania 3
SV - El Salvador 3
TW - Taiwan 3
AM - Armenia 2
BH - Bahrain 2
BN - Brunei Darussalam 2
GD - Grenada 2
GE - Georgia 2
HU - Ungheria 2
IS - Islanda 2
KH - Cambogia 2
Totale 14.657
Salva come PNG Salva come JPEG
Città #
Moscow 751
Ashburn 713
Dublin 613
Hong Kong 530
Singapore 519
Council Bluffs 431
Nyköping 349
San Jose 337
Dallas 277
Princeton 271
Messina 165
Beijing 157
Los Angeles 120
Santa Clara 110
Medford 107
Chandler 86
New York 81
Ho Chi Minh City 79
São Paulo 76
Nuremberg 61
Lauterbourg 60
Hanoi 51
Buffalo 45
Jakarta 45
The Dalles 45
Chicago 44
Redondo Beach 43
Milan 42
Orem 38
Vienna 38
Rome 37
Atlanta 35
Guangzhou 32
Rio de Janeiro 32
Frankfurt am Main 30
Phoenix 30
Pune 29
Mexico City 26
Munich 26
Tianjin 26
Lappeenranta 25
Tashkent 24
Brooklyn 23
Brasília 22
Columbus 22
Tokyo 22
Helsinki 21
Shenzhen 20
Turku 20
Amsterdam 19
Houston 19
Montreal 19
Shanghai 19
Chennai 18
London 18
Porto Alegre 18
Baghdad 17
Naples 17
Quito 17
San Francisco 17
Arezzo 16
Johannesburg 15
Denver 14
Haiphong 14
Memphis 14
Miami 14
Bari 13
Belo Horizonte 13
Campinas 13
Zhengzhou 13
Catania 12
Dhaka 12
Nairobi 12
San José 12
Stockholm 12
Warsaw 12
Biên Hòa 11
Boston 11
Düsseldorf 11
Guayaquil 11
Paternò 11
Bogotá 10
Kingston 10
Montevideo 10
Pittsburgh 10
Portsmouth 10
Rheinfelden 10
Salvador 10
Seattle 10
Sorocaba 10
Bangkok 9
Cairo 9
Florence 9
Las Vegas 9
Poplar 9
Boardman 8
Brno 8
Buenos Aires 8
Cuiabá 8
Curitiba 8
Totale 7.425
Salva come PNG Salva come JPEG
Nome #
Corticosteroids in oncology: Use, overuse, indications, contraindications. An Italian Association of Medical Oncology (AIOM)/ Italian Association of Medical Diabetologists (AMD)/ Italian Society of Endocrinology (SIE)/ Italian Society of Pharmacology (SIF) multidisciplinary consensus position paper 440
Neuropsychiatric Adverse Events with Monoclonal Antibodies Approved for Multiple Myeloma: An Analysis from the FDA Adverse Event Reporting System 264
Safety profile of tyrosine kinase inhibitors used in non-small-cell lung cancer: An analysis from the Italian pharmacovigilance database 241
Immune checkpoint inhibitors and neurotoxicity: a focus on diagnosis and management for a multidisciplinary approach 239
Overexpression of nuclear NHERF1 in advanced colorectal cancer: association with hypoxic microenvironment and tumor invasive phenotype. 188
Autophagic-Related Proteins in Brain Gliomas: Role, Mechanisms, and Targeting Agents 167
Cardiotoxicity Induced by Immune Checkpoint Inhibitors: What a Cardio-Oncology Team Should Know and Do 159
Circulating biomarkers as predictors of response to immune checkpoint inhibitors in NSCLC: Are we on the right path? 155
Crosstalk between ILC3s and Microbiota: Implications for Colon Cancer Development and Treatment with Immune Check Point Inhibitors 155
"Pure" hepatoid tumors of the pancreas harboring CTNNB1 somatic mutations: a new entity among solid pseudopapillary neoplasms 154
A Systematic Review on PD-1 Blockade and PD-1 Gene-Editing of CAR-T Cells for Glioma Therapy: From Deciphering to Personalized Medicine 147
Potential predictive role of gut microbiota to immunotherapy in HCC patients: a brief review 146
Actors on the Scene: Immune Cells in the Myeloma Niche 135
A moonshot approach toward the management of cancer patients in the COVID-19 time: What have we learned and what could the Italian network of cancer centers (Alliance against Cancer, ACC) do after the pandemic wave? 135
Management of Endocrine and Metabolic Toxicities of Immune-Checkpoint Inhibitors: From Clinical Studies to a Real-Life Scenario 134
Basics and frontiers on pancreatic cancer for radiation oncology: Target delineation, SBRT, SIB technique, MRgRT, particle therapy, immunotherapy and clinical guidelines 134
Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trial 133
A Novel Prognostic Tool in Western and Eastern Biliary Tract Cancer Patients Treated in First-line Setting: the ECSIPOT Index 132
Comparison Study of the Safety Profile of Olaparib Versus Niraparib: Analysis of Real-World Data from EudraVigilance 124
Extrahepatic Distal Cholangiocarcinoma vs. Pancreatic Ductal Adenocarcinoma: Histology and Molecular Profiling for Differential Diagnosis and Treatment 122
Rare histotypes of epithelial biliary tract tumors: A literature review 112
Neuropsychiatric adverse drug reactions with oral tyrosine kinase inhibitors in metastatic colorectal cancer: an analysis from the FDA Adverse Event Reporting System 110
Targeted therapies for KRAS-mutant non-small cell lung cancer: from preclinical studies to clinical development-a narrative review 110
Neuropsychiatric Adverse Drug Reactions with Tyrosine Kinase Inhibitors in Gastrointestinal Stromal Tumors: An Analysis from the European Spontaneous Adverse Event Reporting System 110
Challenges and pitfalls in the management of endocrine toxicities from immune checkpoint inhibitors: a case presentation of synchronous thyrotoxicosis and primary adrenal insufficiency in a melanoma patient 110
Dihydropyrimidine Dehydrogenase Polymorphism c.2194G>A Screening Is a Useful Tool for Decreasing Gastrointestinal and Hematological Adverse Drug Reaction Risk in Fluoropyrimidine-Treated Patients 109
Cancer survivorship at heart: a multidisciplinary cardio-oncology roadmap for healthcare professionals 108
Photodynamic therapy with zinc phthalocyanine enhances the anti-cancer effect of tamoxifen in breast cancer cell line: Promising combination treatment against triple-negative breast cancer? 107
Laparoscopic vs. open mesorectal excision for rectal cancer: Are these approaches still comparable? A systematic review and meta-analysis 103
From bench to bedside: highlights from the International Dialogue on Ovarian Cancer 103
A Systematic Review and Meta-Analysis on the Significance of TIGIT in Solid Cancers: Dual TIGIT/PD-1 Blockade to Overcome Immune-Resistance in Solid Cancers 101
The Italian Rare Biliary tract Cancer initiative (IRaBiCa): A multicentric observational study of Gruppo Oncologico dell’Italia Meridionale (GOIM) in collaboration with Gruppo Italiano Colangiocarcinoma (GICO) 100
Moving the target on the optimal adjuvant strategy for resected pancreatic cancers: A systematic review with meta-analysis 99
A Systematic Review on the Therapeutic Potentiality of PD-L1-Inhibiting MicroRNAs for Triple-Negative Breast Cancer: Toward Single-Cell Sequencing-Guided Biomimetic Delivery 98
Antiangiogenic agents after first line and sorafenib plus chemoembolization: A systematic review 98
Clinical practice guidelines for diagnosis, treatment and follow-up of exocrine pancreatic ductal adenocarcinoma: Evidence evaluation and recommendations by the italian association of medical oncology (AIOM) 97
Immune Checkpoint Inhibitors and the Kidney: A Focus on Diagnosis and Management for Personalised Medicine 96
Genomic characterization of undifferentiated sarcomatoid carcinoma of the pancreas 96
FOLFIRINOX after first-line gemcitabine-based chemotherapy in advanced pancreatic cancer: a retrospective comparison with FOLFOX and FOLFIRI schedules 95
A randomized phase III study of fractionated docetaxel, oxaliplatin, capecitabine (low-tox) vs epirubicin, oxaliplatin and capecitabine (eox) in patients with locally advanced unresectable or metastatic gastric cancer: the lega trial 93
A scoping review on the potentiality of PD-L1-inhibiting microRNAs in treating colorectal cancer: Toward single-cell sequencing-guided biocompatible-based delivery 93
A phase I study of capecitabine in combination with vinorelbine in advanced breast cancer 93
A Promising Role of TGF-β Pathway in Response to Regorafenib in Metastatic Colorectal Cancer: A Case Report 92
Somatic BRCA Mutation in a Cholangiocarcinoma Patient for HBOC Syndrome Detection 91
Active treatment given in the last weeks of life: poor quality cancer care or justifiable behavior? 91
Microfluidic-Assisted Preparation of Targeted pH-Responsive Polymeric Micelles Improves Gemcitabine Effectiveness in PDAC: In Vitro Insights 90
Khorana score and thromboembolic risk in stage II–III colorectal cancer patients: a post hoc analysis from the adjuvant TOSCA trial 90
Association of NOS3 and ANGPT2 Gene Polymorphisms with Survival in Patients with Hepatocellular Carcinoma Receiving Sorafenib: Results of the Multicenter Prospective INNOVATE Study 90
The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019 89
The molecular profiling of solid tumors by liquid biopsy: a position paper of the AIOM-SIAPEC-IAP-SIBioC-SIC-SIF Italian Scientific Societies 89
A Systematic Review of the Tumor-Infiltrating CD8+ T-Cells/PD-L1 Axis in High-Grade Glial Tumors: Toward Personalized Immuno-Oncology 89
A prognostic model in patients with advanced biliary tract cancer receiving first-line chemotherapy 89
Expression and characterization of a novel recombinant cytotoxin II from Naja naja oxiana venom: A potential treatment for breast cancer 87
Vaccination for herpes zoster in patients with solid tumors: a position paper on the behalf of the Associazione Italiana di Oncologia Medica (AIOM) 86
Metabolic disorders and gastroenteropancreatic-neuroendocrine tumors (GEP-NETs): How do they influence each other? An Italian Association of Medical Oncology (AIOM)/ Italian Association of Medical Diabetologists (AMD)/ Italian Society of Endocrinology (SIE)/ Italian Society of Pharmacology (SIF) multidisciplinary consensus position paper 86
The role of PNI to predict survival in advanced hepatocellular carcinoma treated with Sorafenib 86
Biomarker phenotyping drives clinical management in axillary sentinel node: A retrospective study on women with primary breast cancer in 2002 86
Anti-angiogenesis and Immunotherapy: Novel Paradigms to Envision Tailored Approaches in Renal Cell-Carcinoma 85
[Apoptosis or programmed cell death: regulatory and pathophysiological mechanisms]. FT Apoptosi, o morte cellulare programmata: meccanismi regolatori e fisiopatologia 85
Combination of Ipilimumab and Nivolumab in Cancers: From Clinical Practice to Ongoing Clinical Trials 85
STAT3 Silencing and TLR7/8 Pathway Activation Repolarize and Suppress Myeloid-Derived Suppressor Cells From Breast Cancer Patients 85
PD-L1 silencing inhibits triple-negative breast cancer development and upregulates T-cell-induced pro-inflammatory cytokines 84
A Systematic Review to Clarify the Prognostic Values of CD44 and CD44+CD24- Phenotype in Triple-Negative Breast Cancer Patients: Lessons Learned and The Road Ahead 84
[Paraneoplastic syndromes of the central nervous system] 84
Cardiovascular Safety Profile of BRAF and MEK Inhibitors in Melanoma: FAERS Data Through a Retrospective Disproportionality Analysis (2014–2023) 83
The prognostic nutritional index predicts survival and response to first-line chemotherapy in advanced biliary cancer 83
A scoping review on the significance of programmed death-ligand 1-inhibiting microRNAs in non-small cell lung treatment: A single-cell RNA sequencing-based study 82
Unveiling cardiovascular and respiratory toxicities with monoclonal antibodies in multiple myeloma: disproportionality analysis from the FDA Adverse Event Reporting System 82
Bortezomib Treatment Modulates Autophagy in Multiple Myeloma 82
Fluropyrimidine single agent or doublet chemotherapy as second line treatment in advanced biliary tract cancer 82
mRNA-COVID19 Vaccination Can Be Considered Safe and Tolerable for Frail Patients 81
Renal Disorders with Oral Tyrosine Kinase Inhibitors in Metastatic Colorectal Cancer: An Analysis from the FDA Adverse Event Reporting System Database 81
Antineoplastic dosing in overweight and obese cancer patients: an Associazione Italiana Oncologia Medica (AIOM)/Associazione Medici Diabetologi (AMD)/Società Italiana Endocrinologia (SIE)/Società Italiana Farmacologia (SIF) multidisciplinary consensus position paper 80
Prediction and validation of GUCA2B as the hub-gene in colorectal cancer based on co-expression network analysis: In-silico and in-vivo study 80
Second-line treatments for Advanced Hepatocellular Carcinoma: A Systematic Review and Bayesian Network Meta-analysis 79
[Indices of disease activity in systemic lupus erythematosus. Review of the literature] 79
Neutrophils, Crucial, or Harmful Immune Cells Involved in Coronavirus Infection: A Bioinformatics Study 78
Exploiting systems biology to investigate the gene modules and drugs in ovarian cancer: A hypothesis based on the weighted gene co-expression network analysis 76
Hydroxy-propil-β-cyclodextrin inclusion complexes of two biphenylnicotinamide derivatives: Formulation and anti-proliferative activity evaluation in pancreatic cancer cell models 76
Immune Checkpoint Inhibitor-Related Myositis: From Biology to Bedside 76
MiR-144: A new possible therapeutic target and diagnostic/prognostic tool in cancers 76
Incidence of patients with bone metastases at diagnosis of solid tumors in adults: a large population-based study 75
[Common variable immunodeficiency]. FT Immunodeficienza comune variabile 75
The combination effect of Prominin1 (CD133) suppression and Oxaliplatin treatment in colorectal cancer therapy 74
Predictors of thyroid adverse events during cancer immunotherapy: a real-life experience at a single center 74
Current approaches for combination therapy of cancer: The role of immunogenic cell death 73
null 72
Prognostic Role and Clinical Significance of Tumor-Infiltrating Lymphocyte (TIL) and Programmed Death Ligand 1 (PD-L1) Expression in Triple-Negative Breast Cancer (TNBC): A Systematic Review and Meta-Analysis Study 72
The latest findings of PD-1/PD-L1 inhibitor application in gynecologic cancers 72
Angiogenesis Genotyping and Clinical Outcomes in Patients with Advanced Hepatocellular Carcinoma Receiving Sorafenib: The ALICE-2 Study 70
Prognostic factors in 868 advanced gastric cancer patients treated with second-line chemotherapy in the real world 70
Italian oncologists and vaccinations against infectious diseases: Results of a survey of the Italian Association of Medical Oncology 69
Clinical and Genomic Characterization of Pancreatic Ductal Adenocarcinoma with Signet-Ring/Poorly Cohesive Cells 68
Polybrominated Diphenyl Ethers (PBDEs) and Human Health: Effects on Metabolism, Diabetes and Cancer 68
Liquid biopsy and tumor heterogeneity in metastatic solid tumors: the potentiality of blood samples 66
Immunotherapy of cancer in single-cell RNA sequencing era: A precision medicine perspective 66
Diabetes management in cancer patients. An Italian Association of Medical Oncology, Italian Association of Medical Diabetologists, Italian Society of Diabetology, Italian Society of Endocrinology and Italian Society of Pharmacology multidisciplinary consensus position paper 66
The importance of immune checkpoints in immune monitoring: A future paradigm shift in the treatment of cancer 65
On the Management of Drug Interactions in the Course of Concomitant Treatments for COVID-19 and Antineoplastic Agents 63
Identification of early diagnostic biomarkers via WGCNA in gastric cancer 63
Totale 10.345
Salva come PNG Salva come JPEG
Categoria #
all - tutte 60.051
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 60.051
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022388 0 0 0 0 0 0 0 0 8 0 0 380
2022/20231.548 307 183 131 7 28 93 32 45 663 9 13 37
2023/2024379 53 58 33 27 33 55 44 10 9 8 6 43
2024/20252.786 66 43 46 127 209 84 126 389 564 233 301 598
2025/20267.385 358 470 572 503 568 1.336 811 838 749 571 298 311
2026/20272.378 382 1.112 725 159 0 0 0 0 0 0 0 0
Totale 14.864